STOCK TITAN

Planned 14,000-share insider sale disclosed for ZVRA (NASDAQ: ZVRA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of the issuer of ZVRA has filed a Rule 144 notice to sell 14,000 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NASDAQ, has an aggregate market value of $124,040.00.

The 14,000 shares were acquired from the issuer as restricted stock units dated 01/30/2026, with the same date listed for payment. The notice also reports 56,297,535 shares of the issuer’s common stock outstanding and confirms the seller represents having no undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ZVRA disclose?

The Form 144 discloses a planned sale of 14,000 ZVRA common shares. The shares, valued at $124,040.00 in total, are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, under Rule 144 for resales of restricted or control securities.

How many ZVRA shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 14,000 shares of ZVRA common stock. These shares have an aggregate market value of $124,040.00 and are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange, subject to Rule 144 conditions.

When are the ZVRA shares scheduled to be sold and on which exchange?

The planned sale date for the 14,000 ZVRA common shares is 01/30/2026. The securities are listed to be sold on the NASDAQ exchange, with Morgan Stanley Smith Barney LLC Executive Financial Services named as the broker handling the transaction.

How were the ZVRA shares in this Form 144 acquired?

The 14,000 ZVRA common shares were acquired on 01/30/2026 as restricted stock units from the issuer. The table lists the acquisition date and a corresponding date of payment of 01/30/2026, with the nature of payment indicated as “N/A” in the filing.

How many ZVRA shares are reported outstanding in this filing?

The Form 144 reports that 56,297,535 shares of the issuer’s common stock are outstanding. This figure provides context for the 14,000 shares covered by the planned Rule 144 sale, which represent only a small portion of the total outstanding shares.

What representation does the selling person make in the ZVRA Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the standard representation language included in Rule 144 notice forms.
Zevra Therapeutics Inc

NASDAQ:ZVRA

ZVRA Rankings

ZVRA Latest News

ZVRA Latest SEC Filings

ZVRA Stock Data

498.80M
54.85M
0.69%
65.12%
12.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
CELEBRATION